Stereotaxis (STXS) Current Assets (2010 - 2026)
Stereotaxis' (STXS) quarterly Current Assets came in at $36.0 million in Q1 2026, up 39.03% year-over-year from $25.9 million in Q1 2025, and up 6.43% quarter-over-quarter from $33.8 million in Q4 2025.
Analysis
Stereotaxis (STXS) Current Assets (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Current Assets for 17 consecutive years, with $36.0 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Current Assets rose 39.03% year-over-year to $36.0 million in Q1 2026; TTM through Mar 2026 was $36.0 million, a 39.03% increase from a year earlier, with the FY2025 full-year figure at $33.8 million, up 28.03% from the prior year.
- Current Assets was $36.0 million for Q1 2026 at Stereotaxis, up from $33.8 million in the prior quarter.
- Over five years, Current Assets peaked at $47.1 million in Q1 2022 and troughed at $21.9 million in Q2 2025.
- A 5-year average of $34.7 million and a median of $33.8 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets fell 27.84% in 2024 and surged 39.03% in 2026, its largest moves.
- Over 5 years, Current Assets stood at $43.2 million in 2022, then decreased by 23.07% to $33.3 million in 2023, then decreased by 20.52% to $26.4 million in 2024, then rose by 28.03% to $33.8 million in 2025, then rose by 6.43% to $36.0 million in 2026.
- The last three Current Assets figures came in at $36.0 million (Q1 2026), $33.8 million (Q4 2025), and $26.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 36.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 36.03 Mn |
| Dec 31, 2025 | 33.85 Mn |
| Sep 30, 2025 | 26.66 Mn |
| Jun 30, 2025 | 21.90 Mn |
| Mar 31, 2025 | 25.91 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Sep 30, 2024 | 28.81 Mn |
| Jun 30, 2024 | 28.07 Mn |
| Mar 31, 2024 | 31.21 Mn |
| Dec 31, 2023 | 33.27 Mn |
| Sep 30, 2023 | 35.51 Mn |
| Jun 30, 2023 | 38.90 Mn |
| Mar 31, 2023 | 40.91 Mn |
| Dec 31, 2022 | 43.25 Mn |
| Sep 30, 2022 | 46.08 Mn |
| Jun 30, 2022 | 46.64 Mn |
| Mar 31, 2022 | 47.13 Mn |
| Dec 31, 2021 | 51.39 Mn |
| Sep 30, 2021 | 53.41 Mn |
| Jun 30, 2021 | 55.23 Mn |